Scilex Holding Company to Showcase ZTlido at PAINWeek
![Scilex Holding Company to Showcase ZTlido at PAINWeek](https://investorshangout.com/images/blog/ihnews-Scilex%20Holding%20Company%20to%20Showcase%20ZTlido%20at%20PAINWeek.jpg)
Scilex Holding Company to Present Innovations in Pain Management
Palo Alto, California - Scilex Holding Company (NASDAQ: SCLX) is excited to announce its participation in the 2024 Annual PAINWeek Conference. This event, set in the vibrant city of Las Vegas, will take place over three days, showcasing the latest in pain management strategies. Scilex is dedicated to developing innovative non-opioid treatments for both acute and chronic pain, and this conference serves as an excellent platform to share insights and findings.
Highlighting ZTlido (Lidocaine Topical System)
One of the key focuses during the conference will be ZTlido, a lidocaine topical system specifically designed for pain relief associated with neuropathic conditions like postherpetic neuralgia. The conference will feature both oral and poster presentations, enriching the dialogue around non-opioid pain management.
Conference Date Highlights
Attendees can look forward to several exciting presentations scheduled during the conference:
- On September 4, there will be a non-CME presentation led by Dr. Charles Argoff, a highly respected expert in the field. He will discuss alternatives to gabapentinoids for patients who do not achieve sufficient relief.
- The following day, September 5, focuses on two significant poster presentations by Dr. Srinivas Nalamachu. These presentations will cover the analysis of opioid utilization and cost effectiveness when using the lidocaine topical system compared to traditional treatments.
Advancing Non-Opioid Pain Management
Scilex Holding Company’s commitment to advancing non-opioid pain management solutions is underscored by its innovative products. In addition to ZTlido, the company also offers ELYXYB, an FDA-approved oral solution for treating acute migraine conditions, and Gloperba, a unique liquid formulation for gout flare prevention.
Exploring the Landscape of Pain Relief
In light of increasing concerns over opioid prescription rates, Scilex is strategically positioned to fill a critical gap in pain management therapy. The prevalence of chronic pain conditions highlights the urgent need for effective, non-addictive alternatives, which is precisely where Scilex aims to make a difference.
Company Mission and Vision
Headquartered in Palo Alto, Scilex Holding Company is at the forefront of developing and commercializing therapies that improve patient outcomes in pain management. The company's dedication to research and innovation is evident in its diverse portfolio of products. Scilex focuses on conditions with substantial unmet needs, allowing them to capture a significant market share in the growing field of non-opioid therapies.
Contact Information
For further inquiries, Scilex encourages interested parties to reach out through the following channels:
Investors and Media
Scilex Holding Company
960 San Antonio Road
Palo Alto, CA 94303
Office: (650) 516-4310
Email: investorrelations@scilexholding.com
To learn more about Scilex Holding Company and its innovative products, visit www.scilexholding.com.
Frequently Asked Questions
What is ZTlido and how does it work?
ZTlido (lidocaine topical system) is a prescription product designed to relieve neuropathic pain associated with postherpetic neuralgia by delivering lidocaine directly to the affected area.
When is Scilex presenting at the PAINWeek Conference?
Scilex will present several key discussions and posters during the conference, specifically on September 4 and 5, showcasing the benefits of ZTlido.
Who is Dr. Charles Argoff?
Dr. Charles Argoff is a renowned expert in pain management, serving as the speaker for the highlighted presentation on the challenges associated with gabapentinoids.
What other products does Scilex offer?
In addition to ZTlido, Scilex offers ELYXYB for migraines and Gloperba for gout flare prevention, addressing various pain management needs.
How can I contact Scilex for more information?
You can reach Scilex Holding Company via email at info@scilexholding.com or through their website at www.scilexholding.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Intel's Strategy Shifts Amid Stock Challenges
- Svitzer Group Board Transactions Notification
- Hargreave Hale AIM VCT PLC Announces Total Voting Rights
- BridgeBio Reports Positive Outcomes in ATTRibute-CM Study
- Middlefield Canadian Income PCC Updates Net Asset Value
- Total Shares and Voting Rights Update for Zealand Pharma
- Ress Life Investments A/S Announces Latest NAV Update
- Top AI Stocks for Investors to Watch Now
- Cathie Wood's Notable Stock Purchases This Summer
- Davidson Kempner Discloses Position in International Paper Company
- Investing in Top Growth Stocks: AbbVie and Cava Group
- Harris's Housing Strategies and Market Implications
- Smart Greenhouse Market Expected to Reach $3.9 Billion
- Explosion-Proof Equipment Market Set to Reach $13.69 Billion
- Coloplast A/S: Trading Updates from Board Members
- GVRenting Champions Urban Sustainability Initiatives
- US Stocks Surge with Positive Inflation News
- Exploring the Growth of the Powder Coatings Market
- Ready to Eat Food Market Forecast: USD 489.3 Billion by 2034
- Clarification on Fintech360 and Nuvei Collaboration
- Nymox Highlights Annual Report and Treatment Advances
- Keyword Studios Plc: Recent Disclosures by Rathbones Group
- Rivian to Showcase Innovations at Goldman Sachs Conference
- Atlantic Petroleum Reports Q2 2024 Financial Results
- Elevator Consultant Solutions Expands Local Expertise Network
Recent Articles
- Mowi ASA CEO Ivan Vindheim Increases Shareholding
- Housing Market Faces Unprecedented Bubble Concerns
- JPMorgan Refreshes ETF Offerings with New Fund
- Opthea's Financial Growth and Business Progress Report
- Market Outlook: Stocks Rise Ahead of Inflation Data
- OKX Wallet Hosts Discussion on Legacy in Web3
- Intel's Strategic Shift Amid Challenging Times
- Bekaert's Recent Activity Under Liquidity Agreement
- Peter de Laat Takes Charge as Brunel's New CEO
- Projected Growth of Membrane Materials Recycling Market
- OKX Unveils Ultiverse-Themed Cryptopedia Rewards Program
- Challenges Facing Retirees: Linda's Story and Insights
- Perseus Mining Announces Rick Menell as Chairman
- ARCpoint Conference Call for Q2 2024 Financial Results
- Stran & Company Responds to Nasdaq Notification on Filing Delay
- Innovative Ketamine-Based Treatment Collaboration
- Kane Biotech Reports Strong Q2 2024 Financial Performance
- Launch One Acquisition Corp. I Announces Trading of Shares
- Inari Medical Reveals PEERLESS Trial Data at TCT 2024
- Nokia Addresses Stock Trading Activity Concerns
- Virginia Credit Union Welcomes New Board Members Post Merger
- Nokia Corporation Manager Transaction Update
- Nvidia's Future: Analyzing AI Leadership and Stock Potential
- Celebrating National Black Business Month with Thumzup
- Fazoli’s Expands Its Footprint with New Location in Georgia